A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Oesophageal Cancer|Pancreas Adenocarcinoma
Interventions: DRUG: [68Ga]Ga-OncoFAP administration
Sponsor: Philogen S.p.A.